GlassScriptPhysician profile
Katie J Tipton
NPI 1437416716
$2,944.15
in general payments reported to CMS, 2019-2025
37 companies · $591 in 2025
The $591 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $136 · 2021: $325 · 2022: $499 · 2023: $574 · 2024: $689 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,835 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.77 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $762.59 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $378.16 | 2019-2025 | Repatha, Repatha, Otezla |
| Glaxosmithkline, LLC. | $261.31 | 2019-2024 | Shingrix, Arexvy |
| Pfizer INC. | $165.71 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $140.53 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lundbeck LLC | $133.42 | 2021-2025 | Vyepti |
| Astellas Pharma US INC | $122.59 | 2022-2024 | Veozah, Myrbetriq |
| Lilly USA, LLC | $114.07 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Xeris Pharmaceuticals, INC. | $92.48 | 2023-2025 | Gvoke Hypopen |
| Seqirus USA INC | $70.82 | 2022-2024 | Fluad, Flucelvax, Flucelvax Quadrivalent |
| Inspire Medical Systems, INC. | $65.93 | 2023 | Inspire |
| Sanofi-Aventis U.S. LLC | $59.57 | 2024-2025 | |
| Dynavax Technologies Corporation | $47.15 | 2023-2025 | Heplisav-B |
| Exact Sciences Corporation | $46.17 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.52 | 2022-2025 | Jardiance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Tipton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.